141 related articles for article (PubMed ID: 15465149)
21. [Constraints and dosage for prostate cancer patients treated with conformal radiotherapy and intensity modulated radiation therapy].
Chauvet I; Gaboriaud G; Pontvert D; Zefkili S; Giraud P; Rosenwald JC; Cosset JM
Cancer Radiother; 2004 Dec; 8(6):337-51. PubMed ID: 15619378
[TBL] [Abstract][Full Text] [Related]
22. Dose verification with Monte Carlo technique for prostate brachytherapy implants with (125)I sources.
Zhang H; Baker C; McKinsey R; Meigooni A
Med Dosim; 2005; 30(2):85-91. PubMed ID: 15922174
[TBL] [Abstract][Full Text] [Related]
23. Challenge of dose escalation in locally advanced unfavourable prostate cancer using HDR brachytherapy.
Al-Salihi O; Mitra A; Payne H
Prostate Cancer Prostatic Dis; 2006; 9(4):370-3. PubMed ID: 16832383
[TBL] [Abstract][Full Text] [Related]
24. Favorable toxicity and biochemical control using real-time inverse optimization technique for prostate brachytherapy.
Raben A; Rusthoven KE; Sarkar A; Glick A; Benge B; Jacobs D; Raben D
Brachytherapy; 2009; 8(3):297-303. PubMed ID: 19213608
[TBL] [Abstract][Full Text] [Related]
25. Hypofractionated conformal HDR brachytherapy in hormone naïve men with localized prostate cancer. Is escalation to very high biologically equivalent dose beneficial in all prognostic risk groups?
Galalae RM; Martinez A; Nuernberg N; Edmundson G; Gustafson G; Gonzalez J; Kimming B
Strahlenther Onkol; 2006 Mar; 182(3):135-41. PubMed ID: 16520907
[TBL] [Abstract][Full Text] [Related]
26. Investigating the role of constrained CVT and CVT in HIPO inverse planning for HDR brachytherapy of prostate cancer.
Sachpazidis I; Hense J; Mavroidis P; Gainey M; Baltas D
Med Phys; 2019 Jul; 46(7):2955-2968. PubMed ID: 31055834
[TBL] [Abstract][Full Text] [Related]
27. Dosimetric comparison of inverse optimization with geometric optimization in combination with graphical optimization for HDR prostate implants.
Jamema SV; Saju S; Shetty UM; Pallad S; Deshpande DD; Shrivastava SK
J Med Phys; 2006 Apr; 31(2):89-94. PubMed ID: 21206671
[TBL] [Abstract][Full Text] [Related]
28. Impact of prostate catheter displacement in inverse planning--simulated annealing and geometric optimization.
Reynés-Llompart G; Pino F; Modolell I; Gullón C; Pera J; Gutierrez C; Picón C
Brachytherapy; 2016; 15(1):112-7. PubMed ID: 26612698
[TBL] [Abstract][Full Text] [Related]
29. High-dose-rate brachytherapy for large prostate volumes (> or =50cc)-Uncompromised dosimetric coverage and acceptable toxicity.
Monroe AT; Faricy PO; Jennings SB; Biggers RD; Gibbs GL; Peddada AV
Brachytherapy; 2008; 7(1):7-11. PubMed ID: 18299109
[TBL] [Abstract][Full Text] [Related]
30. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
[TBL] [Abstract][Full Text] [Related]
31. Inverse planning simulated annealing for magnetic resonance imaging-based intracavitary high-dose-rate brachytherapy for cervical cancer.
Kubicky CD; Yeh BM; Lessard E; Joe BN; Speight JL; Pouliot J; Hsu IC
Brachytherapy; 2008; 7(3):242-7. PubMed ID: 18468959
[TBL] [Abstract][Full Text] [Related]
32. An eight-year experience of HDR brachytherapy boost for localized prostate cancer: biopsy and PSA outcome.
Bachand F; Martin AG; Beaulieu L; Harel F; Vigneault E
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):679-84. PubMed ID: 18963537
[TBL] [Abstract][Full Text] [Related]
33. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
34. Mixed integer programming improves comprehensibility and plan quality in inverse optimization of prostate HDR brachytherapy.
Gorissen BL; den Hertog D; Hoffmann AL
Phys Med Biol; 2013 Feb; 58(4):1041-57. PubMed ID: 23363622
[TBL] [Abstract][Full Text] [Related]
35. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view.
Nickers P; Thissen B; Jansen N; Deneufbourg JM
Radiother Oncol; 2006 Jan; 78(1):47-52. PubMed ID: 16216365
[TBL] [Abstract][Full Text] [Related]
36. Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations.
Fuller DB; Naitoh J; Lee C; Hardy S; Jin H
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1588-97. PubMed ID: 18374232
[TBL] [Abstract][Full Text] [Related]
37. Interactive multiobjective optimization for anatomy-based three-dimensional HDR brachytherapy.
Ruotsalainen H; Miettinen K; Palmgren JE; Lahtinen T
Phys Med Biol; 2010 Aug; 55(16):4703-19. PubMed ID: 20671355
[TBL] [Abstract][Full Text] [Related]
38. High dose rate brachytherapy for prostate cancer.
Hoskin P
Cancer Radiother; 2008 Nov; 12(6-7):512-4. PubMed ID: 18755623
[TBL] [Abstract][Full Text] [Related]
39. Feasibility of adequate dose coverage in permanent prostate brachytherapy using divergent needle insertion methods.
van den Bosch MR; Lips IM; Lagerburg V; van Vulpen M; Lagendijk JJ; Moerland MA
Radiother Oncol; 2008 Jan; 86(1):120-5. PubMed ID: 18037520
[TBL] [Abstract][Full Text] [Related]
40. Comment on Moerland et al. study of decline of dose coverage between different implant techniques for I125 prostate brachytherapy.
Al-Qaisieh B
Radiother Oncol; 2010 Mar; 94(3):386-7; author reply 386. PubMed ID: 20207039
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
